The Effects of Hyperacute Serum on the Elements of the Human Subchondral Bone Marrow Niche.
Ontology highlight
ABSTRACT: Mesenchymal stem cells (MSCs) are widely used in laboratory experiments as well as in human cell therapy. Their culture requires animal sera like fetal calf serum (FCS) as essential supplementation; however, animal sera pose a risk for clinical applications. Human blood derivatives, for example, platelet-rich plasma (PRP) releasates, are potential replacements of FCS; however, it is unclear which serum variant has the best effect on the given cell or tissue type. Additionally, blood derivatives are commonly used in musculoskeletal diseases like osteoarthritis (OA) or osteonecrosis as "proliferative agents" for the topical MSC pool. Hyperacute serum (HAS), a new serum derivative, has been designed to approximate the natural coagulation cascade with a single-step, additive-free preparation m
SUBMITTER: Simon M
PROVIDER: S-EPMC5926480 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA